Actual costs of cancer drugs in 15 European countries

Affiliations

¹ Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: w.v.harten@nki.nl.
² Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.
³ Centro di Riferimento Oncologico, Aviano, Italy.
⁴ Institut Gustave Roussy, Villejuif, France.
⁵ The Cambridge Cancer Centre, Cambridge, UK.

Wim H van Harten et al. Lancet Oncol. 2016 Jan.

. 2016 Jan;17(1):18-20.

doi: 10.1016/S1470-2045(15)00486-6. Epub 2015 Dec 4.

¹ Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: w.v.harten@nki.nl.
² Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.
³ Centro di Riferimento Oncologico, Aviano, Italy.
⁴ Institut Gustave Roussy, Villejuif, France.
⁵ The Cambridge Cancer Centre, Cambridge, UK.

No abstract available

Comment in

Price, value, and the cost of cancer drugs.
Fojo T, Lo AW. Fojo T, et al. Lancet Oncol. 2016 Jan;17(1):3-5. doi: 10.1016/S1470-2045(15)00564-1. Epub 2015 Dec 23. Lancet Oncol. 2016. PMID: 26758749 No abstract available.
The difficulty of comparing drug prices between countries.
De Block M. De Block M. Lancet Oncol. 2016 Apr;17(4):e125. doi: 10.1016/S1470-2045(16)00176-5. Epub 2016 Mar 29. Lancet Oncol. 2016. PMID: 27300660 No abstract available.
The need for better legislation for generic drug manufacturers.
The Lancet Haematology. The Lancet Haematology. Lancet Haematol. 2017 Jul;4(7):e302. doi: 10.1016/S2352-3026(17)30111-4. Lancet Haematol. 2017. PMID: 28668188 No abstract available.